Olema Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Olema Pharmaceuticals, Inc. has filed 560 SEC EDGAR filings since 27 Aug 2018

SEC filing history

Showing 126-150 of 560 matching filings.

Per page
25
Current page
6
ARS File 001-39712

ARS

Filing date
28 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39712

DEFA14A

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39712

DEF 14A

Filing date
28 Apr 2025
Reporting date
28 Apr 2025
Next action
Verify source filing
S-8 File 333-285882

S-8

Filing date
18 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
28 Feb 2025
Reporting date
18 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91849

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284131

EFFECT filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284146

EFFECT filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-284146

424B5

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-284131

424B3

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Jan 2025
Reporting date
08 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
13 Jan 2025
Reporting date
08 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91849

SCHEDULE 13G/A filing

Filing date
13 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .